First Plenary Session - Friday, 13 September, 8:30 - 10:30
The Role of Data Supporting an Effective Decision-Making Process
Many of the processes of everyday life have become increasingly automated. The sheer volume and diversity of data that are currently applied to healthcare have grown exponentially as medical technology and integrated solutions have made this information increasingly accessible and useful for healthcare decision makers.
Real-world data extends the usefulness of randomized controlled trials by its ability to include timely data, large sample sizes that enable analysis of subpopulations and less common effects, and real-world practice and behaviors in applied research studies. Research that uses real-world data and real-world evidence are becoming increasingly important to decision makers, and through careful analysis and interpretation, this type of evidence will play an increasing role in informing healthcare decisions.
In the session entitled “The Role of Data Supporting Effective Decision-Making Processes,” different stakeholders will explore how the management of these “data” impact real-life healthcare decisions and resource allocation in Latin America.
Moderator:Manuel Antonio Espinoza, MD, MSc, PhD, Pontificia Universidad Catolica, Chile
- William Crown, MA, PhD, OptumLabs, USA
- Rafael Alfonso, MD, MSc, PhD, GSK, USA
- Oscar Espinosa, MD, MSc, Institute of Technology Assessment in Health, Colombia
- Edson Amaro Jr, MD, PhD, Hospital Israelita Albert Einstein, Brazil
Second Plenary Session
Value Measurement in 2020: Moving Forward in Low- to Middle-Income Countries
Based on the delivery model of value-based healthcare, “value” is determined by measuring health outcomes against the cost of delivering the outcomes. However, value measurement in health involves some important decisions about what to measure and how. Which key outcomes determine how the efficiency of a health system should be measured? How can the perspectives of all stakeholders be incorporated, thus making patients and providers partners in healthcare decisions? And, how can patients’ access to innovation be effectively managed so that it adds value and improves health system efficiency?
In the session entitled “Value Measurement in 2020: Moving Forward in Low- to Middle-Income Countries,” panelists will present different approaches to increase efficiency in health systems and improve access to patients.
Moderator:Mariana Barraza Llorens, MSc, Blutitude Healthcare Intelligency, Mexico
- Hector Castro, MD, MSc, PhD, Management Sciences for Health, Washington, DC, USA
- Alejandro Gaviria, PhD, Former Ministry of Health Colombia, Colombia
- Cristina Gutiérrez Delgado,PhD, Economic Evaluation Unit, Health Secretariat, Mexico
- Analia Lopez, MD, MSc, Chief of Cabinet, Health Secretariat, Ministry of Health and Social Development, Argentina